Vertex Pharmaceuticals Inc. (VRTX)

Index: Nasdaq 100
0.52%
$0.70
$135.53
23:26 22/06/17
$135.53
23:26 22/06/17
DAILY VARIATION
0.52%
$0.70
VOLUME
2,890,075
DATA
52 Week High
n/a
52 Week Low
n/a
Shares Issued
249.07m
Market Cap
$33,756.29m
RiskGrade
n/a
Beta
n/a
MENU

Vertex Pharmaceuticals Inc. Overview

Vertex Pharmaceuticals Incorportated in a United States-based drug manufacturer. The company focuses on the research and development of small molecule drugs that are used in the treatment of diseases, including HIV infection & chronic hepatitis C virus.

Intraday Chart

Historic Charts

Latest F'cast
Div Yield 0.0% 0.0%
Div Cover n/a n/a
Op Mrgn -45.2% 13.5%
ROCE 0.0%
Latest F'cast
P/E -58.4 7,395.8
PEG 0.0 0.8
Pr/Revenue 32.5 14.3
Pr/Book 30.7
Latest F'cast
Revenue 77.9% -14.6%
PBT 0.0% n/a
EPS 0.0% -49.7%
DPS n/a 0.0%

Key Fundamentals

slide to see more
Year Ending Revenue ($m) Pre-tax ($m) EPS P/E PEG EPS Grth. Div Yield
2012-12-31 1,527.04 -12.38 -50.00¢ -83.8 0.0 n/a n/a 0.0%
2013-12-31 1,211.97 -626.04 -198.00¢ -37.5 0.0 n/a n/a 0.0%
2014-12-31 580.41 -734.88 -314.00¢ -37.8 0.0 n/a n/a 0.0%
2015-12-31 1,032.34 -557.80 -231.00¢ -54.5 0.0 n/a n/a 0.0%

Forecast

slide to see more
Year Ending Revenue ($m) Pre-tax ($m) EPS P/E PEG EPS Grth. Div Yield
2016-12-31 1,702.17 -68.29 85.00c 14,487.1 n/a 0% 0.00c 0.0%
2017-12-31 2,147.63 289.39 164.40c 7,395.8 79.2 93% 0.00c 0.0%
2018-12-31 2,616.03 575.32 302.85c 4,104.7 48.7 84% 0.00c 0.0%

Regulatory News

No results found

Newspaper Links

No results found